Sunesis to Present at the 11th Annual BIO CEO & Investor Conference
February 04 2009 - 8:00AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., Feb. 4 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), a biopharmaceutical
company focused on the development and commercialization of new
oncology therapeutics for the treatment of solid and hematologic
cancers, today announced that the company will be presenting at the
upcoming 11th Annual BIO CEO & Investor Conference at 11:30
a.m. Eastern Time on February 10, 2009 at the Waldorf-Astoria Hotel
in New York City, NY. The live webcast of this presentation will be
available on the Sunesis website at http://ir.sunesis.com/. A
replay of the webcast will be archived on the "Calendar of Events"
page in the Investors and Media section of the Sunesis website for
two weeks. About Sunesis Pharmaceuticals Sunesis is a
biopharmaceutical company focused on the development and
commercialization of new oncology therapeutics for the treatment of
solid and hematologic cancers. Sunesis has built a highly
experienced cancer drug development organization committed to
advancing voreloxin in multiple indications to improve the lives of
people with cancer. For additional information on Sunesis
Pharmaceuticals, please visit http://www.sunesis.com/. SUNESIS and
the logo are trademarks of Sunesis Pharmaceuticals, Inc.
DATASOURCE: Sunesis Pharmaceuticals, Inc. CONTACT: Eric Bjerkholt
of Sunesis Pharmaceuticals, Inc., +1-650-266-3717 Web site:
http://www.sunesis.com/
Copyright
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Oct 2023 to Oct 2024